Guidance for industry : 180-day generic drug exclusivity under the Hatch-Waxman amendments to the Federal Food, Drug, and Cosmetic Act.
| Corporate Author: | |
|---|---|
| Format: | Government Document eBook |
| Language: | English |
| Published: |
Rockville, MD :
U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,
[1998]
|
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/LPS120164 |
Internet
https://purl.fdlp.gov/GPO/LPS120164Available Online
| Call Number: |
HE 20.4702:EX 2/3 |
|
|---|---|---|
| Call Number | Status | Get It |
| HE 20.4702:EX 2/3 | Available | |